Category: Results
-
REACH Niger publishes important results demonstrating efficacy of azithromycin in reducing child mortality
Writing in the prestigious New England Journal of Medicine, the AVENIR study group demonstrate that distributing azithromycin twice a year to children aged 1 to 59 months significantly reduced mortality and that including older children in treatment was more effective than targeting infants aged 1 to 11 months only.